Skip to main content
logo
Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
17.57
-1.42 (-7.48%)
At close: Nov 5, 2026, 4:00 PM EST
17.18
-0.39 (-2.22%)
After-hours: Nov 5, 2026, 7:55 PM EST

Sarepta Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,9562,1981,9021,243933.01701.89
Revenue Growth
-18.95%15.58%52.97%33.26%32.93%29.95%
Gross Profit
-411.1-163.43778.36215.61-84.07-160.24
Operating Income
-8.4-657.77218.08-267.82-536.2-443.61
Net Income
-114.62-713.41235.24-535.98-703.49-418.78
Earnings Per Share
-1.09-7.132.34-5.80-8.03-5.15
EPS Growth
------

Revenue by Segment
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total PMO Products
958.64965.57967.17944.52843.77612.4
ELEVIDYS
393.94898.73820.79200.36--
Collaboration and Other
603.77333.94114.0298.4689.2489.49
Revenue (Total)
1,9562,1981,9021,243933.01701.89

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
878.78939.651,3551,6761,9892,116
Total Debt
1,0531,0401,3301,3791,6171,138
Net Cash (Debt)
-174.25-99.925.2297.29372.02977.48
Net Cash Growth
---91.53%-20.09%-61.94%12.91%
Net Cash Per Share
-1.65-1.000.233.224.2512.03

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
185.56-205.48-205.79-500.99-325.35-443.17
Capital Expenditures
-9.16-101.97-136.96-76.11-30.82-38.49
Free Cash Flow
176.4-307.45-342.74-577.1-356.17-481.66
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-21.01%-7.43%40.92%17.34%-9.01%-22.83%
Operating Margin
-0.43%-29.92%11.47%-21.54%-57.47%-63.20%
Pretax Margin
-4.70%-31.94%13.71%-41.83%-73.95%-59.69%
Profit Margin
-5.86%-32.45%12.37%-43.11%-75.40%-59.66%
FCF Margin
9.02%-13.99%-18.02%-46.41%-38.17%-68.62%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--49.37---
Forward PE
77.8190.1215.47---
PS Ratio
0.951.036.117.2612.1911.17